It has come to our attention that a component used in the manufacture of certain lots of our OTC device for motion sickness may not function properly. This problem impacts only the specified lots of the Explorer, model RB-EL, which are listed below.

NMT completed the acquisition of all global rights, corporate assets, technology, trademarks, and intellectual property of Woodside Biomedical, Inc.

NMT reinstated the production and distribution of the ReliefBand® Medical Device in September 2008.

Although no significant differences occurred on the first day of chemotherapy or in overall quality of life scores, significant differences in nausea/vomiting did occur for the overall five-day period. The group with the active Reliefband had significantly less vomiting episodes overall…

Woodside Biomedical, makers of the ReliefBand(R) Device, announced today that it has received 510(k) clearance from the Food and Drug Administration (FDA) to market the device without a prescription to pregnant women for relief of mild to moderate nausea and vomiting associated with pregnancy.